Home
>
National Drug Code (NDC)
>
NEO-POLYCIN HC
NEO-POLYCIN HC - 48102-005-35 - (NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE ACETATE)
Drug Information of NEO-POLYCIN HC
| Product NDC: | 48102-005 |
| Proprietary Name: | NEO-POLYCIN HC |
| Non Proprietary Name: | NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE ACETATE |
| Active Ingredient(s): | 400; 10; 3.5; 10000 U/g; mg/g; mg/g; U/g & nbsp; NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE ACETATE |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NEO-POLYCIN HC
| Product NDC: | 48102-005 |
| Labeler Name: | Fera Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062166 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110701 |
Package Information of NEO-POLYCIN HC
| Package NDC: | 48102-005-35 |
| Package Description: | 1 TUBE in 1 CARTON (48102-005-35) > 3.5 g in 1 TUBE |
NDC Information of NEO-POLYCIN HC
| NDC Code | 48102-005-35 |
| Proprietary Name | NEO-POLYCIN HC |
| Package Description | 1 TUBE in 1 CARTON (48102-005-35) > 3.5 g in 1 TUBE |
| Product NDC | 48102-005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE ACETATE |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20110701 |
| Marketing Category Name | ANDA |
| Labeler Name | Fera Pharmaceuticals |
| Substance Name | BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 10; 3.5; 10000 |
| Strength Unit | U/g; mg/g; mg/g; U/g |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Decreased Cell Wall Synthesis & Repair [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
